Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy

NCT: NCT07516808 · NOT_YET_RECRUITING

NCT IDNCT07516808
StatusNOT_YET_RECRUITING
Start Date2026-06
Completion2027-08-28

Brief Summary

This study will evaluate the use of intraoperative nonlinear microscopy (NLM) for surgical margin assessment during nerve-sparing radical prostatectomy in participants with prostate cancer.

Frequently Asked Questions

What is PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy?

PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy is a clinical trial registered under NCT07516808. Current status: NOT_YET_RECRUITING.

What is the status of NCT07516808?

The current status of NCT07516808 (PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy) is: NOT_YET_RECRUITING.

When did PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy start?

PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑